Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
MA

Mark Ayers — 7 Patents

MPMillennium Pharmaceuticals: 2 patents #358 of 771Top 50%
Merck: 2 patents #3,930 of 9,382Top 45%
UTUniversity Of Texas: 1 patents #37 of 278Top 15%
Bristol-Myers Squibb: 1 patents #2,493 of 3,969Top 65%
Los Osos, CA: #9 of 86 inventorsTop 15%
California: #83,669 of 386,348 inventorsTop 25%
Overall (All Time): #680,018 of 4,157,543Top 20%
7 Patents All Time
Mark Ayers has been granted 7 US patents while listed as an inventor at Millennium Pharmaceuticals. The first was granted in 2007 and the most recent in July 2022. Mark Ayers ranks #680,018 of 4,157,543 US inventors in our database (top 16.4%). Patent records list Mark Ayers in Los Osos, CA, US.

Patents per Year

Patents granted per year, 2007 to 2022Bar chart with a peak of 2 patents in 2022.peak 22007: 1 patents20072009: 1 patents20092011: 1 patents20112012: 1 patents20122019: 1 patents20192022: 2 patents2022

Issued Patents All Time

Showing 1–7 of 7 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
11377693 System and methods for deriving gene signature biomarkers of response to PD-1 antagonists Andrey Loboda, Jared Lunceford, Terrill K. McClanahan, Erin Murphy, Michael Nebozhyn 2022-07-05 $309,260,000
11326211 Blood-based biomarkers of tumor sensitivity to PD-1 antagonists Jared Lunceford, Andrey Loboda, Michael Nebozhyn, Terrill K. McClanahan, Heather Hirsch 2022-05-10 $318,775,000
10222152 Reloadable magazine apparatus configured to accept a plurality of cartridges 2019-03-05
8259483 Non-volatile memory module 2012-09-04
8067189 Methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators by measuring the level of collagen type IV 2011-11-29 $47,215,000
7504222 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer Jim Stec, Andrew I. Damokosh, Edwin Clark, Kenneth Hess, Gabriel N. Hortobagyi +3 more 2009-03-17
7195868 Compositions and methods for the identification, assessment, prevention, and therapy of human cancers Natalia Iartchouk, Jeffrey Brown 2007-03-27 $7,163,000